TBK1 and neoplasm: In vivo experiments using nude mice, both amlexanox treatment and TBK1 knockdown significantly inhibited xenograft tumor growth, and also reduced the levels of EMT-related proteins as well as phosphorylated AKT and NF-κB in the tumor tissues (176).